Skip to Content
Uncategorized

Making Safer Nanomedicine

Nontoxic silicon nanoparticles soak up drugs like a sponge and break down into smaller particles that are cleared by the kidneys
February 23, 2009
Credit: UC San Diego.

Some nanomaterials can ferry cancer drugs to tumors; others can act as bright contrast agents for infrared or magnetic-resonance imaging.

While researchers are working to make these materials even more efficient tumor targeters and imaging agents, they will also need to make sure they are safe. But until now, “there has been little effort to engineer the self-destruction [of nanomaterials]…into non-toxic, systemically-eliminated products,” write researchers in this week’s issue of Nature Materials.

The researchers, from MIT and University of California, have now developed nanomaterials and carefully characterized their degradation into non-toxic breakdown products that are cleared from the body in urine. Because the materials are photoluminescent, it’s possible to see whether or not they’ve reached a tumor. Mouse studies demonstrate that the particles are not only harmless, but that they soak up cancer drugs like sponges. The particles, which range in size from about 130 to 180 nanometers (the ideal size for getting into tumors via leaky blood vessels) are riddled with 5 to 10 nanometer holes. As the the particles break down inside a tumor, the drugs come out.

The nanoparticles haven’t been tested in clinical trials yet, but there is good reason to suspect they’ll be harmless in people. For one thing, earlier this month researchers presented results at the American Association for the Advancement of Science meeting of a gene expression study demonstrating that exposing human immune cells to silica particles with a range of different surface areas didn’t harm the cells. And the researchers felt comfortable enough to expose themselves for the above photo, which shows the nanoparticles emitting fluorescent light under UV.

Deep Dive

Uncategorized

Embracing CX in the metaverse

More than just meeting customers where they are, the metaverse offers opportunities to transform customer experience.

Identity protection is key to metaverse innovation

As immersive experiences in the metaverse become more sophisticated, so does the threat landscape.

The modern enterprise imaging and data value chain

For both patients and providers, intelligent, interoperable, and open workflow solutions will make all the difference.

Scientists have created synthetic mouse embryos with developed brains

The stem-cell-derived embryos could shed new light on the earliest stages of human pregnancy.

Stay connected

Illustration by Rose Wong

Get the latest updates from
MIT Technology Review

Discover special offers, top stories, upcoming events, and more.

Thank you for submitting your email!

Explore more newsletters

It looks like something went wrong.

We’re having trouble saving your preferences. Try refreshing this page and updating them one more time. If you continue to get this message, reach out to us at customer-service@technologyreview.com with a list of newsletters you’d like to receive.